申请人:Bayer Schering Pharma Aktiengesellschaft
公开号:EP1916003A1
公开(公告)日:2008-04-30
The present invention relates to nucleoside analogues and more particularly to labelled nucleoside analogues of formula (I). It has been found new thymidine analogues can be stably labelled with a detectable label moiety. Further the present invention relates to methods of making above compounds and use of such compounds for diagnostic imaging of tumor cells and I or treatment of proliferative diseases. In addition, the present invention relates to the preparation and use of positron emitting compounds for positron emission tomography (PET). A kit is also disclosed.
本发明涉及核苷类似物,更特别地涉及式(I)的标记核苷类似物。已发现新的胸苷类似物可以稳定地标记具有可检测标记基团。此外,本发明涉及制备上述化合物的方法以及利用这些化合物进行肿瘤细胞的诊断成像和/或治疗增殖性疾病。此外,本发明涉及制备和使用正电子发射化合物进行正电子发射断层扫描(PET)。还公开了一种试剂盒。